Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s disease

Plasma biomarkers for Alzheimer’s disease-related pathologies have undergone rapid developments during the past few years, and there are now well-validated blood tests for amyloid and tau pathology, as well as neurodegeneration and astrocytic activation. To define Alzheimer’s disease with biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevenson-Hoare, Joshua, Heslegrave, Amanda, Leonenko, Ganna, Fathalla, Dina, Bellou, Eftychia, Luckcuck, Lauren, Marshall, Rachel, Sims, Rebecca, Morgan, Bryan Paul, Hardy, John, de Strooper, Bart, Williams, Julie, Zetterberg, Henrik, Escott-Price, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924904/
https://www.ncbi.nlm.nih.gov/pubmed/35383826
http://dx.doi.org/10.1093/brain/awac128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924904/
https://www.ncbi.nlm.nih.gov/pubmed/35383826
http://dx.doi.org/10.1093/brain/awac128

Ejemplares similares